Beranda › Miastenia Gravis › Texas › Dallas
Uji klinis Miastenia Gravis di Dallas, TX
6 studi untuk Miastenia Gravis mencari peserta di lokasi sekitar Dallas (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
Menerima pesertaFase 3
- Texas Neurology, Dallas
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Menerima pesertaFase 3
- Baylor Scott & White Research Institute - Baylor Scott & White Research Institute, Dallas
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Menerima pesertaFase 3
- Site Number - 1003, Dallas
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
Menerima pesertaFase 3
- University of Texas Southwestern Medical Center, Dallas
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Menerima pesertaFase 1
- UT Southwestern Medical Center, Dallas
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Menerima pesertaStudi observasional
- Clinical Trial Site, Dallas
Uji klinis Miastenia Gravis di kota lain
- Tampa, FL12 studi
- Houston, TX11 studi
- Durham, NC10 studi
- Boca Raton, FL10 studi
- Columbus, OH8 studi
- Milwaukee, WI7 studi
- St. Louis, MO7 studi
- New York City, NY7 studi
- Miami, FL7 studi
- Jacksonville, FL6 studi
- Chattanooga, TN6 studi
- Boston, MA6 studi
Studi lain di Dallas
- Kanker Payudara55 studi
- Kanker Paru Non-Sel Kecil52 studi
- Kanker Metastatik42 studi
- Gagal Jantung42 studi
- Kanker (semua jenis)37 studi
- Kanker Prostat36 studi
- Kanker Kolorektal33 studi
- Obesitas30 studi
- Kanker Ovarium28 studi
- Kanker Kandung Kemih27 studi
- Kanker Paru27 studi
- Kanker Endometrium24 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.